Explore

Trendline Trendline
INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107

INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107

INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107
Trendline Trendline
Immunome Submits NDA for Varegacestat and Reports Financial Results

Immunome Submits NDA for Varegacestat and Reports Financial Results

Immunome Submits NDA for Varegacestat and Reports Financial Results
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Trendline Trendline
Zura Bio Appoints Muzammil Mustufa as Chief Business Officer to Enhance Strategic Growth

Zura Bio Appoints Muzammil Mustufa as Chief Business Officer to Enhance Strategic Growth

Zura Bio Appoints Muzammil Mustufa as Chief Business Officer to Enhance Strategic Growth
Trendline Trendline
Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials

Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials

Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials
Trendline Trendline
Exobiosphere and Voyager Technologies Collaborate on ISS Biotech Mission

Exobiosphere and Voyager Technologies Collaborate on ISS Biotech Mission

Exobiosphere and Voyager Technologies Collaborate on ISS Biotech Mission
Trendline Trendline
Hiteck and LexBio Unveil HT016 VAV1 Molecular Glue Degrader at AAI 2026

Hiteck and LexBio Unveil HT016 VAV1 Molecular Glue Degrader at AAI 2026

Hiteck and LexBio Unveil HT016 VAV1 Molecular Glue Degrader at AAI 2026
Trendline Trendline
Lupin Seeks Officers for Biotechnology Roles in Pune Facility

Lupin Seeks Officers for Biotechnology Roles in Pune Facility

Lupin Seeks Officers for Biotechnology Roles in Pune Facility
Trendline Trendline
Inhibrx Reports First Quarter 2026 Financial Results Highlighting Clinical Progress

Inhibrx Reports First Quarter 2026 Financial Results Highlighting Clinical Progress

Inhibrx Reports First Quarter 2026 Financial Results Highlighting Clinical Progress
Trendline Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Trendline Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials